The CRC is the Ideal Partner

to Develop your Clinical Trial Project.

Accelerated Drug Development

Through Integration of Pharmacology And Clinical Know-How

CRC - Centro Ricerche Cliniche di Verona

medical image

The Centro Ricerche Cliniche di Verona (CRC) was founded in 2005 and is located in the G.B. Rossi General Hospital. It is owned and operated by The Verona University Hospital and Verona University.

Our mission is to assist both commercial and non-profit research organizations in early clinical drug development. The objectives of the CRC are to:

Conduct Phase I and Proof-of-Concept clinical trials to the highest standards of quality and with rapid turn-around;
Support the development of interdisciplinary scientific collaboration;
Share facilities and know-how with private or public organizations involved in pharmacological research;
Support non-profit research using CRC profits.

Please, visit our Healthy Volunteers web site >>

See more about us »

Study Types

study types image

The CRC specialises in designing and executing Proof-of-Concept studies using targeted populations, state-of-the-art technology and human disease.

A full range of Clinical Pharmacology services is also provided (e.g. single/multiple ascending dose, drug-drug interaction, pharmacokinetics, food effects, bioequivalence) by means of an in-house Clinical Pharmacology Unit, equipped to the highest standards and operating in close connection with specialist intensive care expertise in Cardiology, Anaesthesiology, Internal Medicine, Surgery and Neurology.

See more about our Clinical Pharmacology Unit »

Our Quality System

medical image

The CRC is in full compliance with International Good Clinical Practice (GCP) standards and is Certified according to the UNI EN ISO 9001:2008 standard; transition to the 9001:2015 ISO standard has been completed in 2018.

The CRC Quality Management System (QMS) comprises our mechanisms for ensuring that all our services are performed to the highest ethical standards, conform to all regulatory requirements and satisfies contractual obligations.

We continually improve the effectiveness of its QMS through a systematic approach, starting from defining and planning strategy and objectives in order to standardize implementation and compliance by a defined Quality Policy and procedures, checking effectiveness and compliance by QA, QC, Management Review, data and project review, audits and customer survey results.

See more about our QS »

CRC News

12/20/2021	Study iONCTURA results. Stefano Milleri has presented results from a healthy volunteer study showing that IOA-289, our novel #Autotaxin inhibitor, lowered circulating levels of #LPA, a blood-based biomarker of autotaxin inhibition, in a dose-dependent manner. Compelling preclinical data show IOA-289 reduces tumor burden in mouse pancreatic cancer models. This supports the decision to advance IOA-289 into clinical studies in #pancreaticcancer, a malignancy typically characterized by a fibrotic and immune excluded phenotype. Importantly, LPA levels have been shown to correlate with circulating CA19-9, a clinical biomarker of pancreatic cancer progression, providing a strong rationale for a biomarker-evaluable-response in this study. The data on IOA-289 have been presented in a poster (P131) entitled “Translating a novel autotaxin inhibitor from preclinical proof of concept in pancreatic cancer to a biomarker response in human subjects”. The poster is available here. (click HERE to read the document)
08/12/2021	Il CRC attribuisce una borsa di studio per un/una CTA. Maggiori dettagli a questo link vedi scheda Invia il tuo CV entro il 25/08/2021 Il bando e la domanda sono disponibili a questo link Bando e domanda per borsa di studio CTA Puoi utilizzare il modulo per l'invio della domanda alla pagina work with us oppure inviarla per mail a info@crc.vr.it
08/12/2021	Il CRC cerca n. 2 infermieri/e. Maggiori dettagli a questo link vedi scheda Invia il tuo CV entro il 25/08/2021 Puoi utilizzare il modulo per l'invio del CV alla pagina work with us oppure inviarlo per mail a info@crc.vr.it
08/12/2021	Il CRC attribuisce una borsa di studio per un/una farmacista. Maggiori dettagli a questo link vedi scheda Invia il tuo CV entro il 25/08/2021 Il bando e la domanda sono disponibili a questo link Bando e domanda per borsa di studio farmacista Puoi utilizzare il modulo per l'invio della domanda alla pagina work with us oppure inviarla per mail a info@crc.vr.it
12/21/2020	Merry Christmas and Happy New Year!
08/03/2020	Start of clinical study with GRAd-COV2 vaccine We are pleased to announce the start of the RT-CoV-2 clinical trial to evaluate the safety and efficacy of the new vaccine to prevent SARS-CoV-2 infection. The study is aimed at healthy subjects aged 18 to 55 years and 65 to 85 years.
07/29/2020	Recent Oncological Publications Download:
06/22/2020	Special Thanks CRC has received a special thanks from INCYTE for the INCB54828-302 study team in progress at CRC. The Verona Center has distinguished itself for the recruitment of patients. Download:

;